Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Other notable trials in this space include the LEADER trial (liraglutide), the SUSTAIN-6 trial (semaglutide), and the REWIND trial (dulaglutide)
Lancet 2 , 244247 (1989)
Therefore, we expanded our CRISPR screening efforts to identify determinants of giredestrant response (Supplementary Fig
Nakamura, K., Yamamoto, H., Morishita, K., et al
For each paper reviewed, information regarding the study setting, participant demographic information, exclusion criteria used for the study, interventional dosage for intervention studies, outcome variable and covariates were independently extracted by two reviewers (D.K
US$ 28.64
US$ 25.81
US$ 28.76
US$ 22.18
US$ 28.12
US$ 24.16
/https://s3-images.chiaki.vn/seller/1780492951197/cloud-image-1780492951197-image.png)
